Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges
•Background of lentiviral and adeno-associated virus vector design.•Reviewing of literature that reported in vivo microglial transduction.•Challenges to overcome low microglial transduction efficiency and specificity.•Guidelines for reporting viral transduction in microglia. Microglia have emerged a...
Gespeichert in:
| Veröffentlicht in: | Neuroscience letters 2019-08, Vol.707, p.134310-134310, Article 134310 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 134310 |
|---|---|
| container_issue | |
| container_start_page | 134310 |
| container_title | Neuroscience letters |
| container_volume | 707 |
| creator | Maes, Margaret E. Colombo, Gloria Schulz, Rouven Siegert, Sandra |
| description | •Background of lentiviral and adeno-associated virus vector design.•Reviewing of literature that reported in vivo microglial transduction.•Challenges to overcome low microglial transduction efficiency and specificity.•Guidelines for reporting viral transduction in microglia.
Microglia have emerged as a critical component of neurodegenerative diseases. Genetic manipulation of microglia can elucidate their functional impact in disease. In neuroscience, recombinant viruses such as lentiviruses and adeno-associated viruses (AAVs) have been successfully used to target various cell types in the brain, although effective transduction of microglia is rare. In this review, we provide a short background of lentiviruses and AAVs, and strategies for designing recombinant viral vectors. Then, we will summarize recent literature on successful microglial transductions in vitro and in vivo, and discuss the current challenges. Finally, we provide guidelines for reporting the efficiency and specificity of viral targeting in microglia, which will enable the microglial research community to assess and improve methodologies for future studies. |
| doi_str_mv | 10.1016/j.neulet.2019.134310 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6734419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304394019303842</els_id><sourcerecordid>2235061848</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-b21eab0bcfbcf05d12e4d20170e92ac79ae051edcdc54412c114dab6e721590e3</originalsourceid><addsrcrecordid>eNp9UdtKxDAQDaLoevkDkT760jWTpO3WB2FZvIEgiOtrSJPZbpZeNGlX_HuzdL29CIGBzJkzZ84h5BToGCikF6txg32F3ZhRyMfABQe6Q0YwyVic5RnbJSPKqYh5LugBOfR-RSlNIBH75IADJBPB2YjMn5UrsbNNGdVWu7asrIrebbeMKmw6u7au95FqTDSdvlxGT6jDb6TMWjUah4bDWtlmQ6CXqgpTJfpjsrdQlceTbT0i85vr59ld_PB4ez-bPsRapLyLCwaoClroRXg0McBQmHBORjFnSme5wqAYjTY6EQKYBhBGFSlmDJKcIj8iVwPva1_UARfEOVXJV2dr5T5kq6z822nsUpbtWqYZD4R5IDjfErj2rUffydp6jVWlGmx7LxnjCU1hIiYBKgZocMl7h4vvNUDlJhG5kkMicpOIHBIJY2e_JX4PfUXwcwMGo9YWnfTaYrDXWIe6k6a1_2_4BOMJoLI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2235061848</pqid></control><display><type>article</type><title>Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Maes, Margaret E. ; Colombo, Gloria ; Schulz, Rouven ; Siegert, Sandra</creator><creatorcontrib>Maes, Margaret E. ; Colombo, Gloria ; Schulz, Rouven ; Siegert, Sandra</creatorcontrib><description>•Background of lentiviral and adeno-associated virus vector design.•Reviewing of literature that reported in vivo microglial transduction.•Challenges to overcome low microglial transduction efficiency and specificity.•Guidelines for reporting viral transduction in microglia.
Microglia have emerged as a critical component of neurodegenerative diseases. Genetic manipulation of microglia can elucidate their functional impact in disease. In neuroscience, recombinant viruses such as lentiviruses and adeno-associated viruses (AAVs) have been successfully used to target various cell types in the brain, although effective transduction of microglia is rare. In this review, we provide a short background of lentiviruses and AAVs, and strategies for designing recombinant viral vectors. Then, we will summarize recent literature on successful microglial transductions in vitro and in vivo, and discuss the current challenges. Finally, we provide guidelines for reporting the efficiency and specificity of viral targeting in microglia, which will enable the microglial research community to assess and improve methodologies for future studies.</description><identifier>ISSN: 0304-3940</identifier><identifier>EISSN: 1872-7972</identifier><identifier>DOI: 10.1016/j.neulet.2019.134310</identifier><identifier>PMID: 31158432</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adeno-associated virus (AAV) ; Animals ; Brain ; Dependovirus - genetics ; Gene Targeting ; Genetic Vectors ; HIV-1 - genetics ; Humans ; In-vivo transduction ; Lentivirus ; Lentivirus - genetics ; Microglia ; Microglia - metabolism ; Transduction, Genetic</subject><ispartof>Neuroscience letters, 2019-08, Vol.707, p.134310-134310, Article 134310</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>2019 The Authors 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-b21eab0bcfbcf05d12e4d20170e92ac79ae051edcdc54412c114dab6e721590e3</citedby><cites>FETCH-LOGICAL-c463t-b21eab0bcfbcf05d12e4d20170e92ac79ae051edcdc54412c114dab6e721590e3</cites><orcidid>0000-0001-8635-0877 ; 0000-0001-9434-8902</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304394019303842$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31158432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maes, Margaret E.</creatorcontrib><creatorcontrib>Colombo, Gloria</creatorcontrib><creatorcontrib>Schulz, Rouven</creatorcontrib><creatorcontrib>Siegert, Sandra</creatorcontrib><title>Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges</title><title>Neuroscience letters</title><addtitle>Neurosci Lett</addtitle><description>•Background of lentiviral and adeno-associated virus vector design.•Reviewing of literature that reported in vivo microglial transduction.•Challenges to overcome low microglial transduction efficiency and specificity.•Guidelines for reporting viral transduction in microglia.
Microglia have emerged as a critical component of neurodegenerative diseases. Genetic manipulation of microglia can elucidate their functional impact in disease. In neuroscience, recombinant viruses such as lentiviruses and adeno-associated viruses (AAVs) have been successfully used to target various cell types in the brain, although effective transduction of microglia is rare. In this review, we provide a short background of lentiviruses and AAVs, and strategies for designing recombinant viral vectors. Then, we will summarize recent literature on successful microglial transductions in vitro and in vivo, and discuss the current challenges. Finally, we provide guidelines for reporting the efficiency and specificity of viral targeting in microglia, which will enable the microglial research community to assess and improve methodologies for future studies.</description><subject>Adeno-associated virus (AAV)</subject><subject>Animals</subject><subject>Brain</subject><subject>Dependovirus - genetics</subject><subject>Gene Targeting</subject><subject>Genetic Vectors</subject><subject>HIV-1 - genetics</subject><subject>Humans</subject><subject>In-vivo transduction</subject><subject>Lentivirus</subject><subject>Lentivirus - genetics</subject><subject>Microglia</subject><subject>Microglia - metabolism</subject><subject>Transduction, Genetic</subject><issn>0304-3940</issn><issn>1872-7972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UdtKxDAQDaLoevkDkT760jWTpO3WB2FZvIEgiOtrSJPZbpZeNGlX_HuzdL29CIGBzJkzZ84h5BToGCikF6txg32F3ZhRyMfABQe6Q0YwyVic5RnbJSPKqYh5LugBOfR-RSlNIBH75IADJBPB2YjMn5UrsbNNGdVWu7asrIrebbeMKmw6u7au95FqTDSdvlxGT6jDb6TMWjUah4bDWtlmQ6CXqgpTJfpjsrdQlceTbT0i85vr59ld_PB4ez-bPsRapLyLCwaoClroRXg0McBQmHBORjFnSme5wqAYjTY6EQKYBhBGFSlmDJKcIj8iVwPva1_UARfEOVXJV2dr5T5kq6z822nsUpbtWqYZD4R5IDjfErj2rUffydp6jVWlGmx7LxnjCU1hIiYBKgZocMl7h4vvNUDlJhG5kkMicpOIHBIJY2e_JX4PfUXwcwMGo9YWnfTaYrDXWIe6k6a1_2_4BOMJoLI</recordid><startdate>20190810</startdate><enddate>20190810</enddate><creator>Maes, Margaret E.</creator><creator>Colombo, Gloria</creator><creator>Schulz, Rouven</creator><creator>Siegert, Sandra</creator><general>Elsevier B.V</general><general>Elsevier Scientific Publishers Ireland</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8635-0877</orcidid><orcidid>https://orcid.org/0000-0001-9434-8902</orcidid></search><sort><creationdate>20190810</creationdate><title>Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges</title><author>Maes, Margaret E. ; Colombo, Gloria ; Schulz, Rouven ; Siegert, Sandra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-b21eab0bcfbcf05d12e4d20170e92ac79ae051edcdc54412c114dab6e721590e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adeno-associated virus (AAV)</topic><topic>Animals</topic><topic>Brain</topic><topic>Dependovirus - genetics</topic><topic>Gene Targeting</topic><topic>Genetic Vectors</topic><topic>HIV-1 - genetics</topic><topic>Humans</topic><topic>In-vivo transduction</topic><topic>Lentivirus</topic><topic>Lentivirus - genetics</topic><topic>Microglia</topic><topic>Microglia - metabolism</topic><topic>Transduction, Genetic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maes, Margaret E.</creatorcontrib><creatorcontrib>Colombo, Gloria</creatorcontrib><creatorcontrib>Schulz, Rouven</creatorcontrib><creatorcontrib>Siegert, Sandra</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuroscience letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maes, Margaret E.</au><au>Colombo, Gloria</au><au>Schulz, Rouven</au><au>Siegert, Sandra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges</atitle><jtitle>Neuroscience letters</jtitle><addtitle>Neurosci Lett</addtitle><date>2019-08-10</date><risdate>2019</risdate><volume>707</volume><spage>134310</spage><epage>134310</epage><pages>134310-134310</pages><artnum>134310</artnum><issn>0304-3940</issn><eissn>1872-7972</eissn><abstract>•Background of lentiviral and adeno-associated virus vector design.•Reviewing of literature that reported in vivo microglial transduction.•Challenges to overcome low microglial transduction efficiency and specificity.•Guidelines for reporting viral transduction in microglia.
Microglia have emerged as a critical component of neurodegenerative diseases. Genetic manipulation of microglia can elucidate their functional impact in disease. In neuroscience, recombinant viruses such as lentiviruses and adeno-associated viruses (AAVs) have been successfully used to target various cell types in the brain, although effective transduction of microglia is rare. In this review, we provide a short background of lentiviruses and AAVs, and strategies for designing recombinant viral vectors. Then, we will summarize recent literature on successful microglial transductions in vitro and in vivo, and discuss the current challenges. Finally, we provide guidelines for reporting the efficiency and specificity of viral targeting in microglia, which will enable the microglial research community to assess and improve methodologies for future studies.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>31158432</pmid><doi>10.1016/j.neulet.2019.134310</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-8635-0877</orcidid><orcidid>https://orcid.org/0000-0001-9434-8902</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0304-3940 |
| ispartof | Neuroscience letters, 2019-08, Vol.707, p.134310-134310, Article 134310 |
| issn | 0304-3940 1872-7972 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6734419 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adeno-associated virus (AAV) Animals Brain Dependovirus - genetics Gene Targeting Genetic Vectors HIV-1 - genetics Humans In-vivo transduction Lentivirus Lentivirus - genetics Microglia Microglia - metabolism Transduction, Genetic |
| title | Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A34%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20microglia%20with%20lentivirus%20and%20AAV:%20Recent%20advances%20and%20remaining%20challenges&rft.jtitle=Neuroscience%20letters&rft.au=Maes,%20Margaret%20E.&rft.date=2019-08-10&rft.volume=707&rft.spage=134310&rft.epage=134310&rft.pages=134310-134310&rft.artnum=134310&rft.issn=0304-3940&rft.eissn=1872-7972&rft_id=info:doi/10.1016/j.neulet.2019.134310&rft_dat=%3Cproquest_pubme%3E2235061848%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2235061848&rft_id=info:pmid/31158432&rft_els_id=S0304394019303842&rfr_iscdi=true |